Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma
Open Access
- 29 October 2020
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2020, 1-9
Abstract
Expression of MAPK and PI3K/AKT/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma: Aims. Chronic liver disease (CLD) of different etiologies leads to hepatocellular carcinoma (HCC) by multiple mechanisms that may be translated into clinicopathological differences. We evaluated the tissue expression of the MAPK and PI3K/Akt/mTOR pathway proteins and their association with long-term outcome and other parameters, according to the etiology of the CLD, in HCC patients. Methods. Clinicopathological data from 80 patients who underwent orthotopic liver transplantation for HCC treatment in a Brazilian referral center were compared according to CLD etiology. Event (tumor recurrence or death from any cause) occurrence and event-free survival (EFS) were analyzed. Pathway protein expression was assessed by immunohistochemistry (IHQ) in both tumor and underlying cirrhosis and by RT-PCR in tumor tissue. Results. Strong expression (SE) of KRAS was more frequent in tumors arising from viral (26.8%) than the nonviral group of liver disease (7.7%, ) and also than cirrhotic parenchyma (0%, ). SE of PI3K was more frequent in tumor than in cirrhosis ( , ), without differences in its tumor expression among etiologic groups . mRNA of ERK, PI3K, and BRAF was expressed in the tumor, without differences between CLD etiologies, and there was no association with IHQ findings. Older age and microvascular invasion (MIV) were the only parameters independently associated with the event. MIV was also associated with shorter EFS. Conclusions. Hepatitis B and C virus can lead to HCC by different mechanisms compared with nonviral hepatopathy. KRAS and PI3K may have a role in carcinogenesis. The prognostic and therapeutic implications need to be investigated.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Pró-Reitoria de Pesquisa, Universidade Federal de Minas Gerais
This publication has 42 references indexed in Scilit:
- Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancerCell Cycle, 2013
- A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic VariabilityAnnals of Surgical Oncology, 2012
- HCV core protein promotes heparin binding EGF‐like growth factor expression and activates AktHepatology Research, 2011
- The role of signaling pathways in the development and treatment of hepatocellular carcinomaOncogene, 2010
- mTOR and cancer: many loops in one pathwayCurrent Opinion in Cell Biology, 2010
- Pivotal Role of mTOR Signaling in Hepatocellular CarcinomaGastroenterology, 2008
- Recent advances in the natural history of hepatocellular carcinomaCarcinogenesis, 2008
- Improved RT-PCR Amplification for Molecular Analyses with Long-term Preserved Formalin-fixed, Paraffin-embedded Tissue SpecimensJournal of Histochemistry & Cytochemistry, 2006
- mTOR and P70 S6 Kinase Expression in Primary Liver NeoplasmsClinical Cancer Research, 2004
- The Hallmarks of CancerCell, 2000